オーソバイオロジクスの世界市場 2023-2027

当レポートでは、オーソバイオロジクスの市場規模は、2022年から2027年の間に26億3,844万米ドルの増加が見込まれ、予測期間中に7.88%のCAGRで成長すると予測しています。

当レポートでは、オーソバイオロジクス市場の全体的な分析、市場規模と予測、動向、成長促進要因・課題、約25のベンダーを網羅したベンダー分析などをお届けします。

現在の市場動向と促進要因、市場環境全体に関する最新の分析を提供しています。市場は、高齢化に伴う整形外科疾患の有病率の増加、整形外科手術の減少に向けた取り組みの増加、整形生物学的製剤の承認・認可の増加によって牽引されています。

本調査では、新製品の開発の増加が、今後数年間のオーソバイオロジクス市場の成長を促進する主要な理由の1つであると位置付けています。また、新たな技術革新と生物学的製剤の人気の高まりは、市場の大きな需要につながるでしょう。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2022
• 市場の見通し：2022-2027年の予測

第4章 市場規模実績

• 世界のオーソバイオロジクス市場2017年～2021年
• アプリケーションセグメント別分析2017～2021年
• 製品セグメント別分析2017-2021
• 地域セグメント分析2017-2021
• 国セグメント分析2017-2021

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 アプリケーション別市場セグメンテーション

• マーケット・セグメント
• 用途別比較
• 脊椎固定術 - 市場規模と予測 2022-2027
• 再建手術 - 市場規模と予測 2022-2027
• 外傷修復 - 市場規模と予測 2022-2027
• その他 - 市場規模と予測 2022-2027
• アプリケーション別の市場機会

第7章 製品別の市場セグメンテーション

• マーケット・セグメント
• 製品別比較
• 骨移植代用品 - 市場規模と予測 2022-2027
• 関節内補充療法 - 市場規模と予測 2022-2027
• 幹細胞 - 市場規模と予測 2022-2027
• 製品別の市場機会

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米 - 市場規模と予測 2022-2027
• 欧州 - 市場規模と予測 2022-2027
• アジア - 市場規模と予測 2022-2027
• その他の地域（ROW） - 市場規模と予測 2022-2027
• 米国 - 市場規模と予測 2022-2027
• 英国 - 市場規模と予測 2022-2027
• ドイツ - 市場規模と予測 2022-2027
• 中国 - 市場規模と予測 2022-2027
• カナダ - 市場規模と予測 2022-2027
• 地域情勢別の市場機会

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Advanced Medical Solutions Group Plc
• Anika Therapeutics Inc.
• Arthrex Inc.
• Bioventus LLC
• Globus Medical Inc.
• Johnson and Johnson
• Medtronic Plc
• Nuvasive Inc
• Orthofix Medical Inc.
• OrthoPediatrics Corp.
• ROYAL BIOLOGICS
• RTI Surgical Inc.
• SeaSpine Holdings Corp.
• Smith and Nephew plc
• Stryker Corp.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Application
• Exhibits6: Executive Summary - Chart on Market Segmentation by Product
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on Global orthobiologics market 2017 - 2021 ($ million)
• Exhibits19: Historic Market Size - By Application Segment 2017 - 2021 ($ million)
• Exhibits20: Historic Market Size - By Product Segment 2017 - 2021 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Application - Market share 2022-2027 (%)
• Exhibits31: Data Table on Application - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Application
• Exhibits33: Data Table on Comparison by Application
• Exhibits34: Chart on Spinal fusion - Market size and forecast 2022-2027 ($ million)
• Exhibits35: Data Table on Spinal fusion - Market size and forecast 2022-2027 ($ million)
• Exhibits36: Chart on Spinal fusion - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Spinal fusion - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Reconstructive surgery - Market size and forecast 2022-2027 ($ million)
• Exhibits39: Data Table on Reconstructive surgery - Market size and forecast 2022-2027 ($ million)
• Exhibits40: Chart on Reconstructive surgery - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Reconstructive surgery - Year-over-year growth 2022-2027 (%)
• Exhibits42: Chart on Trauma repair - Market size and forecast 2022-2027 ($ million)
• Exhibits43: Data Table on Trauma repair - Market size and forecast 2022-2027 ($ million)
• Exhibits44: Chart on Trauma repair - Year-over-year growth 2022-2027 (%)
• Exhibits45: Data Table on Trauma repair - Year-over-year growth 2022-2027 (%)
• Exhibits46: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits48: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibits49: Data Table on Others - Year-over-year growth 2022-2027 (%)
• Exhibits50: Market opportunity by Application ($ million)
• Exhibits51: Chart on Product - Market share 2022-2027 (%)
• Exhibits52: Data Table on Product - Market share 2022-2027 (%)
• Exhibits53: Chart on Comparison by Product
• Exhibits54: Data Table on Comparison by Product
• Exhibits55: Chart on Bone graft substitutes - Market size and forecast 2022-2027 ($ million)
• Exhibits56: Data Table on Bone graft substitutes - Market size and forecast 2022-2027 ($ million)
• Exhibits57: Chart on Bone graft substitutes - Year-over-year growth 2022-2027 (%)
• Exhibits58: Data Table on Bone graft substitutes - Year-over-year growth 2022-2027 (%)
• Exhibits59: Chart on Viscosupplementation - Market size and forecast 2022-2027 ($ million)
• Exhibits60: Data Table on Viscosupplementation - Market size and forecast 2022-2027 ($ million)
• Exhibits61: Chart on Viscosupplementation - Year-over-year growth 2022-2027 (%)
• Exhibits62: Data Table on Viscosupplementation - Year-over-year growth 2022-2027 (%)
• Exhibits63: Chart on Stem cells - Market size and forecast 2022-2027 ($ million)
• Exhibits64: Data Table on Stem cells - Market size and forecast 2022-2027 ($ million)
• Exhibits65: Chart on Stem cells - Year-over-year growth 2022-2027 (%)
• Exhibits66: Data Table on Stem cells - Year-over-year growth 2022-2027 (%)
• Exhibits67: Market opportunity by Product ($ million)
• Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits69: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits71: Chart on Geographic comparison
• Exhibits72: Data Table on Geographic comparison
• Exhibits73: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits75: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits76: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits79: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits83: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits89: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibits90: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibits91: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits92: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits93: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits95: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibits96: Data Table on UK - Year-over-year growth 2022-2027 (%)
• Exhibits97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits99: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits101: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibits102: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibits103: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibits104: Data Table on China - Year-over-year growth 2022-2027 (%)
• Exhibits105: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits106: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits107: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits108: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits109: Market opportunity By Geographical Landscape ($ million)
• Exhibits110: Impact of drivers and challenges in 2022 and 2027
• Exhibits111: Overview on Criticality of inputs and Factors of differentiation
• Exhibits112: Overview on factors of disruption
• Exhibits113: Impact of key risks on business
• Exhibits114: Vendors covered
• Exhibits115: Matrix on vendor position and classification
• Exhibits116: Advanced Medical Solutions Group Plc - Overview
• Exhibits117: Advanced Medical Solutions Group Plc - Business segments
• Exhibits118: Advanced Medical Solutions Group Plc - Key offerings
• Exhibits119: Advanced Medical Solutions Group Plc - Segment focus
• Exhibits120: Anika Therapeutics Inc. - Overview
• Exhibits121: Anika Therapeutics Inc. - Product / Service
• Exhibits122: Anika Therapeutics Inc. - Key offerings
• Exhibits123: Arthrex Inc. - Overview
• Exhibits124: Arthrex Inc. - Product / Service
• Exhibits125: Arthrex Inc. - Key offerings
• Exhibits126: Bioventus LLC - Overview
• Exhibits127: Bioventus LLC - Business segments
• Exhibits128: Bioventus LLC - Key news
• Exhibits129: Bioventus LLC - Key offerings
• Exhibits130: Bioventus LLC - Segment focus
• Exhibits131: Globus Medical Inc. - Overview
• Exhibits132: Globus Medical Inc. - Product / Service
• Exhibits133: Globus Medical Inc. - Key offerings
• Exhibits134: Johnson and Johnson - Overview
• Exhibits135: Johnson and Johnson - Business segments
• Exhibits136: Johnson and Johnson - Key news
• Exhibits137: Johnson and Johnson - Key offerings
• Exhibits138: Johnson and Johnson - Segment focus
• Exhibits139: Medtronic Plc - Overview
• Exhibits140: Medtronic Plc - Business segments
• Exhibits141: Medtronic Plc - Key news
• Exhibits142: Medtronic Plc - Key offerings
• Exhibits143: Medtronic Plc - Segment focus
• Exhibits144: Nuvasive Inc - Overview
• Exhibits145: Nuvasive Inc - Business segments
• Exhibits146: Nuvasive Inc - Key news
• Exhibits147: Nuvasive Inc - Key offerings
• Exhibits148: Nuvasive Inc - Segment focus
• Exhibits149: Orthofix Medical Inc. - Overview
• Exhibits150: Orthofix Medical Inc. - Business segments
• Exhibits151: Orthofix Medical Inc. - Key news
• Exhibits152: Orthofix Medical Inc. - Key offerings
• Exhibits153: Orthofix Medical Inc. - Segment focus
• Exhibits154: OrthoPediatrics Corp. - Overview
• Exhibits155: OrthoPediatrics Corp. - Business segments
• Exhibits156: OrthoPediatrics Corp. - Key news
• Exhibits157: OrthoPediatrics Corp. - Key offerings
• Exhibits158: OrthoPediatrics Corp. - Segment focus
• Exhibits159: ROYAL BIOLOGICS - Overview
• Exhibits160: ROYAL BIOLOGICS - Product / Service
• Exhibits161: ROYAL BIOLOGICS - Key offerings
• Exhibits162: RTI Surgical Inc. - Overview
• Exhibits163: RTI Surgical Inc. - Product / Service
• Exhibits164: RTI Surgical Inc. - Key offerings
• Exhibits165: SeaSpine Holdings Corp. - Overview
• Exhibits166: SeaSpine Holdings Corp. - Business segments
• Exhibits167: SeaSpine Holdings Corp. - Key offerings
• Exhibits168: SeaSpine Holdings Corp. - Segment focus
• Exhibits169: Smith and Nephew plc - Overview
• Exhibits170: Smith and Nephew plc - Business segments
• Exhibits171: Smith and Nephew plc - Key news
• Exhibits172: Smith and Nephew plc - Key offerings
• Exhibits173: Smith and Nephew plc - Segment focus
• Exhibits174: Stryker Corp. - Overview
• Exhibits175: Stryker Corp. - Business segments
• Exhibits176: Stryker Corp. - Key news
• Exhibits177: Stryker Corp. - Key offerings
• Exhibits178: Stryker Corp. - Segment focus
• Exhibits179: Inclusions checklist
• Exhibits180: Exclusions checklist
• Exhibits181: Currency conversion rates for US$
• Exhibits182: Research methodology
• Exhibits183: Validation techniques employed for market sizing
• Exhibits184: Information sources
• Exhibits185: List of abbreviations

Technavio has been monitoring the orthobiologics market and is forecast to grow by $2638.44 mn during 2022-2027, accelerating at a CAGR of 7.88% during the forecast period. Our report on the orthobiologics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of orthopedic disorders coupled with an aging population, an increase in focus to reduce orthopedic surgeries, and a rise in approvals and clearances for orthobiologics products.

Technavio's orthobiologics market is segmented as below:

By Application

• Spinal fusion
• Reconstructive surgery
• Trauma repair
• Others

By Product

• Bone graft substitutes
• Viscosupplementation
• Stem cells

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increase in the development of new products as one of the prime reasons driving the orthobiologics market growth during the next few years. Also, emerging technological innovations and the rise in the popularity of orthobiologics will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the orthobiologics market covers the following areas:

• Orthobiologics market sizing
• Orthobiologics market forecast
• Orthobiologics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading orthobiologics market vendors that include Advanced Medical Solutions Group Plc, Anika Therapeutics Inc., Bioventus LLC, Globus Medical Inc., Integra Lifesciences Holdings Corp., Johnson and Johnson, Kuros Biosciences AG, Medtronic Plc, MTF Biologics, Nuvasive Inc, Orthofix Medical Inc., OrthoPediatrics Corp., ROYAL BIOLOGICS, RTI Surgical Inc., SeaSpine Holdings Corp., Smith and Nephew plc, Stryker Corp., Xtant Medical Inc., Zimmer Biomet Holdings Inc., and Arthrex Inc. Also, the orthobiologics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global orthobiologics market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on Global orthobiologics market 2017 - 2021 ($ million)
• 4.2 By Application Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - By Application Segment 2017 - 2021 ($ million)
• 4.3 By Product Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - By Product Segment 2017 - 2021 ($ million)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application

• 6.1 Market segments
• Exhibit 30: Chart on Application - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
• 6.2 Comparison by Application
• Exhibit 32: Chart on Comparison by Application
• Exhibit 33: Data Table on Comparison by Application
• 6.3 Spinal fusion - Market size and forecast 2022-2027
• Exhibit 34: Chart on Spinal fusion - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Spinal fusion - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Spinal fusion - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Spinal fusion - Year-over-year growth 2022-2027 (%)
• 6.4 Reconstructive surgery - Market size and forecast 2022-2027
• Exhibit 38: Chart on Reconstructive surgery - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Reconstructive surgery - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Reconstructive surgery - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Reconstructive surgery - Year-over-year growth 2022-2027 (%)
• 6.5 Trauma repair - Market size and forecast 2022-2027
• Exhibit 42: Chart on Trauma repair - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Trauma repair - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Trauma repair - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Trauma repair - Year-over-year growth 2022-2027 (%)
• 6.6 Others - Market size and forecast 2022-2027
• Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
• 6.7 Market opportunity by Application
• Exhibit 50: Market opportunity by Application ($ million)

7 Market Segmentation by Product

• 7.1 Market segments
• Exhibit 51: Chart on Product - Market share 2022-2027 (%)
• Exhibit 52: Data Table on Product - Market share 2022-2027 (%)
• 7.2 Comparison by Product
• Exhibit 53: Chart on Comparison by Product
• Exhibit 54: Data Table on Comparison by Product
• 7.3 Bone graft substitutes - Market size and forecast 2022-2027
• Exhibit 55: Chart on Bone graft substitutes - Market size and forecast 2022-2027 ($ million)
• Exhibit 56: Data Table on Bone graft substitutes - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Chart on Bone graft substitutes - Year-over-year growth 2022-2027 (%)
• Exhibit 58: Data Table on Bone graft substitutes - Year-over-year growth 2022-2027 (%)
• 7.4 Viscosupplementation - Market size and forecast 2022-2027
• Exhibit 59: Chart on Viscosupplementation - Market size and forecast 2022-2027 ($ million)
• Exhibit 60: Data Table on Viscosupplementation - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Chart on Viscosupplementation - Year-over-year growth 2022-2027 (%)
• Exhibit 62: Data Table on Viscosupplementation - Year-over-year growth 2022-2027 (%)
• 7.5 Stem cells - Market size and forecast 2022-2027
• Exhibit 63: Chart on Stem cells - Market size and forecast 2022-2027 ($ million)
• Exhibit 64: Data Table on Stem cells - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Chart on Stem cells - Year-over-year growth 2022-2027 (%)
• Exhibit 66: Data Table on Stem cells - Year-over-year growth 2022-2027 (%)
• 7.6 Market opportunity by Product
• Exhibit 67: Market opportunity by Product ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 69: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 71: Chart on Geographic comparison
• Exhibit 72: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 UK - Market size and forecast 2022-2027
• Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
• 9.9 Germany - Market size and forecast 2022-2027
• Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.10 China - Market size and forecast 2022-2027
• Exhibit 101: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 102: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 103: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 104: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.11 Canada - Market size and forecast 2022-2027
• Exhibit 105: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 106: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 107: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 108: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 109: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 110: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 112: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 113: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 114: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 115: Matrix on vendor position and classification
• 12.3 Advanced Medical Solutions Group Plc
• Exhibit 116: Advanced Medical Solutions Group Plc - Overview
• Exhibit 117: Advanced Medical Solutions Group Plc - Business segments
• Exhibit 118: Advanced Medical Solutions Group Plc - Key offerings
• Exhibit 119: Advanced Medical Solutions Group Plc - Segment focus
• 12.4 Anika Therapeutics Inc.
• Exhibit 120: Anika Therapeutics Inc. - Overview
• Exhibit 121: Anika Therapeutics Inc. - Product / Service
• Exhibit 122: Anika Therapeutics Inc. - Key offerings
• 12.5 Arthrex Inc.
• Exhibit 123: Arthrex Inc. - Overview
• Exhibit 124: Arthrex Inc. - Product / Service
• Exhibit 125: Arthrex Inc. - Key offerings
• 12.6 Bioventus LLC
• Exhibit 126: Bioventus LLC - Overview
• Exhibit 127: Bioventus LLC - Business segments
• Exhibit 128: Bioventus LLC - Key news
• Exhibit 129: Bioventus LLC - Key offerings
• Exhibit 130: Bioventus LLC - Segment focus
• 12.7 Globus Medical Inc.
• Exhibit 131: Globus Medical Inc. - Overview
• Exhibit 132: Globus Medical Inc. - Product / Service
• Exhibit 133: Globus Medical Inc. - Key offerings
• 12.8 Johnson and Johnson
• Exhibit 134: Johnson and Johnson - Overview
• Exhibit 135: Johnson and Johnson - Business segments
• Exhibit 136: Johnson and Johnson - Key news
• Exhibit 137: Johnson and Johnson - Key offerings
• Exhibit 138: Johnson and Johnson - Segment focus
• 12.9 Medtronic Plc
• Exhibit 139: Medtronic Plc - Overview
• Exhibit 140: Medtronic Plc - Business segments
• Exhibit 141: Medtronic Plc - Key news
• Exhibit 142: Medtronic Plc - Key offerings
• Exhibit 143: Medtronic Plc - Segment focus
• 12.10 Nuvasive Inc
• Exhibit 144: Nuvasive Inc - Overview
• Exhibit 145: Nuvasive Inc - Business segments
• Exhibit 146: Nuvasive Inc - Key news
• Exhibit 147: Nuvasive Inc - Key offerings
• Exhibit 148: Nuvasive Inc - Segment focus
• 12.11 Orthofix Medical Inc.
• Exhibit 149: Orthofix Medical Inc. - Overview
• Exhibit 150: Orthofix Medical Inc. - Business segments
• Exhibit 151: Orthofix Medical Inc. - Key news
• Exhibit 152: Orthofix Medical Inc. - Key offerings
• Exhibit 153: Orthofix Medical Inc. - Segment focus
• 12.12 OrthoPediatrics Corp.
• Exhibit 154: OrthoPediatrics Corp. - Overview
• Exhibit 155: OrthoPediatrics Corp. - Business segments
• Exhibit 156: OrthoPediatrics Corp. - Key news
• Exhibit 157: OrthoPediatrics Corp. - Key offerings
• Exhibit 158: OrthoPediatrics Corp. - Segment focus
• 12.13 ROYAL BIOLOGICS
• Exhibit 159: ROYAL BIOLOGICS - Overview
• Exhibit 160: ROYAL BIOLOGICS - Product / Service
• Exhibit 161: ROYAL BIOLOGICS - Key offerings
• 12.14 RTI Surgical Inc.
• Exhibit 162: RTI Surgical Inc. - Overview
• Exhibit 163: RTI Surgical Inc. - Product / Service
• Exhibit 164: RTI Surgical Inc. - Key offerings
• 12.15 SeaSpine Holdings Corp.
• Exhibit 165: SeaSpine Holdings Corp. - Overview
• Exhibit 166: SeaSpine Holdings Corp. - Business segments
• Exhibit 167: SeaSpine Holdings Corp. - Key offerings
• Exhibit 168: SeaSpine Holdings Corp. - Segment focus
• 12.16 Smith and Nephew plc
• Exhibit 169: Smith and Nephew plc - Overview
• Exhibit 170: Smith and Nephew plc - Business segments
• Exhibit 171: Smith and Nephew plc - Key news
• Exhibit 172: Smith and Nephew plc - Key offerings
• Exhibit 173: Smith and Nephew plc - Segment focus
• 12.17 Stryker Corp.
• Exhibit 174: Stryker Corp. - Overview
• Exhibit 175: Stryker Corp. - Business segments
• Exhibit 176: Stryker Corp. - Key news
• Exhibit 177: Stryker Corp. - Key offerings
• Exhibit 178: Stryker Corp. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 179: Inclusions checklist
• Exhibit 180: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 181: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 182: Research methodology
• Exhibit 183: Validation techniques employed for market sizing
• Exhibit 184: Information sources
• 13.5 List of abbreviations
• Exhibit 185: List of abbreviations